论文部分内容阅读
目的观察盐酸法舒地尔联合依达拉奉治疗急性脑梗死的疗效。方法选择2009年1月至2011年1月住院的急性脑梗死患者62例,随机分为治疗组(30例)和对照组(32例)。治疗组在常规治疗基础上应用盐酸法舒地尔30mg加入生理盐水100ml静脉滴注,2次/d,依达拉奉30mg加入生理盐水100ml静脉滴注,2次/d,治疗10d。对照组在常规治疗基础上应用依达拉奉30mg加入生理盐水100ml静脉滴注,2次/d,治疗10d。2组患者用药前和治疗后进行神经功能缺损程度评分观察疗效。结果治疗组总有效率为93.3%,优于对照组总有效率84.4%,差异有统计学意义(P<0.05)。结论盐酸法舒地尔联合应用依达拉奉治疗急性脑梗死疗效确切,有临床实用价值。
Objective To observe the curative effect of fasudil combined with edaravone on acute cerebral infarction. Methods 62 patients with acute cerebral infarction hospitalized from January 2009 to January 2011 were randomly divided into treatment group (30 cases) and control group (32 cases). On the basis of routine treatment, the treatment group was treated with fasudil hydrochloride 30mg intravenously with 100ml normal saline twice a day, and edaravone 30mg intravenously with 100ml normal saline twice a day for 10 days. In the control group, edaravone 30mg was added to 100ml normal saline intravenously on the basis of routine treatment twice a day for 10 days. Two groups of patients before treatment and after treatment of neurological deficit score observed effect. Results The total effective rate of the treatment group was 93.3%, better than the control group, the total effective rate was 84.4%, the difference was statistically significant (P <0.05). Conclusion Fasudil hydrochloride combined with edaravone in the treatment of acute cerebral infarction is effective and has clinical value.